Trustonic has found another customer for its Trustonic Secured Platform for IoT devices. The company has announced that the medical equipment company OPTOLANE will be using the platform to secure its new LOAA (Lab on an Array) Analyzer.

The LOAA Analyzer is a connected medical device that uses in vitro diagnostic tech (IVD) to evaluate blood and tissue samples. The solution was designed to facilitate the early diagnosis and treatment of cancer, infectious diseases, and congenital abnormalities, and needs only a single cartridge for the entire sample extraction and analysis process.  

The Trustonic Secured Platform, meanwhile, will ensure that patient’s medical information is handled in a secure fashion, encrypting both the information stored on the device and any data that gets sent through the cloud. The LOAA Analyzer is also built with Nexell’s system on chip (SoC) platform, which in turn leverages Trustonic’s Trusted Execution Environment (TEE).

“We fully understand our responsibility to protect patient data,” said OPTOLANE CEO Do Young Lee. “Trustonic’s experience protecting smartphones, wearables and IoT hardware is assurance that our devices and patient data are secured to the highest standard.”

“Where personal data this sensitive is being captured, processed, and transmitted, the appropriate steps must be taken to protect it from malicious actors,” added Trustonic CEO Ben Cade.

OPTOLANE is hoping to clear the LOAA Analyzer with the FDA sometime in the first quarter of 2020, and will make the device widely available once it receives that certification. In the meantime, Trustonic has already secured a range of different IoT applications and devices. Casio deployed the Trustonic Secured Platform to protect its latest PRO TREK smartwatch, and released a new ALPS security app that deactivates lost or stolen mobile devices.

More recently, Trustonic teamed up with Lookout to improve the utility of the App Defense SDK to help safeguard consumer applications.